PXL/HO/BEC-004/2021-22 Dt: 26.04.2021
Dear Sir/Madam,
Sub: Commercial Offer for supply of Remdesivir from Russia- Reg
We are glad to inform the members that Pharmexcil has received a communication from the the Indian embassy in Moscow that a Russian manufacturer of pharmaceutical products, PHARMASYNTEZ has offered to export the drug Remdeform (INN Remdesivir) to India of around three to four lakh packs per week.
It is understood that PHARMASYNTEZ group of companies is one of the largest domestic manufacturers in the Russian Federation and it has acquired the rights to produce and sell the "Remdeform" (Remdesivir, lyophilized powder for injection, generic drug of "Veklury" of Gilead Sciences).
It is furthur learned that PHARMASYNTEZ is interested in negotiating the commercial terms directly with buyers from India and is ready to supply "Remdeform: to India'' on the following terms. Please find attached the offer received from PHARMASYNTEZ.
-
Quantity: 300 000 - 400 000 packs per week
-
Estimated delivery Time (AIr: About 8-10 days)
Taking into account severe shortages through indigenous sources, the Indian Pharma importers may like to consider the Russian offer. Members may kindly be aware that import permissions from CDSCO needs to be taken while importing the said product.
Interested members may directly approach the nodal person of PHARMASYNTEZ given below:
Mr. Evgeniy Dubrovin
BD Director
PHARMASYNTEZ Group of Companies
email id: info@pharmasyntez.com
Tel: + 7 3952 55 03 55
Our Director, Regulatory Affairs - Ms.Lakshmi Prasanna (email is: regulatory@pharmexcil.com) would be ready to assist any interested company.
Warm Regards
Udaya Bhaskar
Director General
Encl: Pharmazyntez
Important Note: Members may please note that the above information is circulated on the basis of information received from Pharmazyntez, Russia. Members are advised to make their own decisions before finalizing their business transactions.
|
